Literature DB >> 11152374

Levels of nitric oxide in the heart after experimental myocardial ischemia.

S Lecour1, V Maupoil, M Zeller, A Laubriet, T Briot, L Rochette.   

Abstract

The effect of myocardial ischemia on nitric oxide (NO) production is controversial in part because of indirect NO quantification. In the present study, direct quantification of NO was investigated in an in vivo rat model of myocardial ischemia (MI). A NO spin-trapping technique using electron spin resonance (ESR) spectroscopy was used to study NO production in the ischemic and in the nonischemic area of the rat heart 2, 8, or 24 h after left main coronary artery ligation. The method was based on the trapping of NO by a metal-chelator complex consisting of N-methyl-D-glucamine-dithiocarbamate (MGD) and Fe(II) to form a stable NO-FeMGD complex that gives rise to a characteristic triplet ESR spectrum. This metal-chelator complex was administered half an hour before sacrifice of the rats. A large and time-dependent increase of the ESR signal corresponding to the NO-FeMGD complex was observed 8 h (11.6 +/- 0.9 arbitrary units [AU]) and 24 h (29.7 +/- 2.9 AU) in the ischemic area after MI. On the contrary, no ESR triplet was observed in the nonischemic region of the heart and in sham-operated rats. NO blood derivative levels (nitrosylhemoglobin and plasma nitrites and nitrates) were unchanged compared with sham-operated rats. Previous administration of aminoguanidine, a NO synthase inhibitor, in animals subjected to a 24-h ischemia resulted in a complete abolition in the NO-FeMGD spectrum in the ischemic area. These findings directly demonstrated an increase of the NO-FeMGD levels during in vivo myocardial ischemia that appeared to be specifically localized in the ischemic area.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11152374     DOI: 10.1097/00005344-200101000-00007

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  5 in total

Review 1.  Nitric oxide: an emerging role in cardioprotection?

Authors:  R D Rakhit; M S Marber
Journal:  Heart       Date:  2001-10       Impact factor: 5.994

2.  Histamine 3 receptor activation reduces the expression of neuronal angiotensin II type 1 receptors in the heart.

Authors:  Narumi Hashikawa-Hobara; Noel Yan-Ki Chan; Roberto Levi
Journal:  J Pharmacol Exp Ther       Date:  2011-10-19       Impact factor: 4.030

3.  Effect of aminoguanidine on ischemia-reperfusion induced myocardial injury in rats.

Authors:  Hakan Parlakpinar; Mehmet Kaya Ozer; Ahmet Acet
Journal:  Mol Cell Biochem       Date:  2005-09       Impact factor: 3.396

4.  NO production results in suspension-induced muscle atrophy through dislocation of neuronal NOS.

Authors:  Naoki Suzuki; Norio Motohashi; Akiyoshi Uezumi; So-ichiro Fukada; Tetsuhiko Yoshimura; Yasuto Itoyama; Masashi Aoki; Yuko Miyagoe-Suzuki; Shin'ichi Takeda
Journal:  J Clin Invest       Date:  2007-09       Impact factor: 14.808

5.  New perspectives of nitric oxide donors in cardiac arrest and cardiopulmonary resuscitation treatment.

Authors:  Peter Kruzliak; Olga Pechanova; Tomas Kara
Journal:  Heart Fail Rev       Date:  2014-05       Impact factor: 4.214

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.